항균 및 감염 관리 제품 시장 예측(-2034년) : 제품 유형, 유통 채널, 용도, 최종사용자 및 지역별 분석

According to Stratistics MRC, the Global Antimicrobial & Infection Control Products Market is accounted for $28.9 billion in 2026 and is expected to reach $45.3 billion by 2034 growing at a CAGR of 5.8% during the forecast period. Antimicrobial & Infection Control Products comprise various solutions used to minimize, prevent, and manage the transmission of harmful microorganisms across healthcare, commercial, household, and industrial settings. The category covers disinfectants, sanitizing agents, antimicrobial coatings, cleaning products, sterilization technologies, protective equipment, and hygiene solutions. These products help maintain cleaner environments by limiting microbial presence on surfaces, medical equipment, hands, and high-contact areas. Growing attention to hygiene standards, infection prevention, and contamination management is supporting wider use of antimicrobial and infection control products across diverse applications.

According to the World Health Organization (WHO), out of every 100 patients in acute-care hospitals, 7 patients in high-income countries and 15 patients in low- and middle-income countries acquire at least one healthcare-associated infection (HAI) during their hospital stay, demonstrating the continuing need for infection prevention and control products.

Market Dynamics:

Driver:

Rising healthcare-associated infection prevention

Increasing emphasis on controlling healthcare-associated infections is supporting the adoption of antimicrobial and infection control products. Healthcare facilities, including hospitals, clinics, laboratories, and long-term care centers, are expanding their use of disinfectants, sanitizers, sterilization solutions, antimicrobial coatings, and protective equipment. Enhanced infection prevention procedures and stronger awareness of hygiene requirements encourage organizations to improve sanitation and contamination control. The ongoing priority of safeguarding patients, medical personnel, and visitors from harmful microorganisms continues to create demand for effective antimicrobial and infection control solutions across healthcare settings.

Restraint:

Stringent regulatory requirements

Strict regulatory standards may limit growth in the Antimicrobial & Infection Control Products Market by raising development expenses and extending commercialization timelines. Products such as disinfectants, sterilization solutions, antimicrobial coatings, and related technologies generally require testing to verify their safety, performance, and regulatory compliance. Manufacturers may also face additional validation procedures, documentation requirements, and quality evaluations before products can enter targeted markets. Such requirements can increase business costs and create entry challenges for smaller manufacturers, potentially delaying innovations and restricting expansion into certain application areas.

Opportunity:

Development of advanced antimicrobial technologies

Advancements in antimicrobial technologies are creating new growth opportunities within the Antimicrobial & Infection Control Products Market. Companies are working on improved disinfectants, durable antimicrobial coatings, treated surfaces, and other solutions that provide enhanced control of microorganisms. Progress in material engineering and formulation techniques can contribute to greater product performance, longevity, and versatility across different applications. Such innovations can encourage adoption in hospitals, food processing facilities, workplaces, transportation systems, and industrial locations. Ongoing research and development can further expand product portfolios and enable wider market opportunities.

Threat:

Emergence of antimicrobial-resistant microorganisms

Increasing antimicrobial resistance represents a potential threat to the Antimicrobial & Infection Control Products Market because resistant microorganisms can limit the performance of some existing antimicrobial solutions. Managing resistant organisms may require more advanced infection prevention approaches, especially within healthcare settings. Companies may therefore need continuous investment in new formulations, technologies, and antimicrobial mechanisms to respond to evolving microbial challenges. Higher research and development requirements can raise costs and create uncertainties concerning product effectiveness, regulatory compliance, market acceptance, and sustained use across different infection control applications.

Covid-19 Impact:

COVID-19 created a strong increase in demand for antimicrobial and infection control products as hospitals, workplaces, commercial facilities, and households adopted stricter sanitation measures. Consumption of disinfectants, hand sanitizers, protective equipment, and sterilization solutions rose as organizations focused on limiting virus transmission. Healthcare providers also reinforced infection prevention protocols to safeguard patients and medical personnel. While demand for certain pandemic-related products declined after emergency conditions diminished, lasting awareness of hygiene, microbial contamination, and preventive sanitation continued encouraging use across diverse healthcare and non-healthcare settings.

The disinfectants & sanitizers segment is expected to be the largest during the forecast period

The disinfectants & sanitizers segment is expected to account for the largest market share during the forecast period because of their extensive use across healthcare, commercial, industrial, and household settings. They are commonly applied to hands, surfaces, equipment, workplaces, and high-contact areas to control microbial contamination and maintain hygiene. Hospitals, clinics, laboratories, food-processing facilities, offices, and homes regularly depend on these products for sanitation purposes. The availability of multiple formulations suited to different surfaces, environments, and cleaning requirements further strengthens the segment's widespread utilization.

The healthcare providers segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the healthcare providers segment is predicted to witness the highest growth rate as healthcare facilities increasingly prioritize infection prevention, patient safety, and contamination control. Hospitals, clinics, diagnostic centers, and laboratories require consistent use of disinfectants, sterilization equipment, protective products, and other infection-control solutions. Expansion of healthcare infrastructure and stronger infection-prevention protocols are encouraging broader adoption of these products. Growing awareness of healthcare-associated infections, combined with investments in modern medical facilities and advanced infection-control technologies, is expected to support continued demand from healthcare providers and strengthen their growth within the market.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, driven by developed healthcare systems, established hygiene standards, and growing emphasis on preventing infections. Hospitals and other healthcare facilities regularly utilize disinfectants, sterilization technologies, protective barriers, antimicrobial coatings, and related consumables. Robust regulatory frameworks and well-developed medical infrastructure support consistent product adoption throughout the region. In addition, the presence of established manufacturers, ongoing technological advancements, and considerable healthcare expenditure strengthen North America's position as the largest regional market for these products.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, driven by improving medical infrastructure, stronger hygiene awareness, and increasing focus on infection prevention. Healthcare facilities are adopting more advanced disinfection, sterilization, protective, and antimicrobial solutions to strengthen contamination control. Rising healthcare expenditure and infrastructure development across China, India, Japan, and Southeast Asia are also encouraging product adoption. Expanding healthcare services, greater infection-control awareness, and modernization of medical facilities are expected to sustain the region's rapid growth throughout the forecast period.

Key players in the market

Some of the key players in Antimicrobial & Infection Control Products Market include 3M Company, Steris plc, Ecolab Inc., Getinge AB, Belimed AG, Reckitt Benckiser Group plc, B. Braun Melsungen AG, Kimberly-Clark Corporation, Cardinal Health, Inc., Becton, Dickinson and Company (BD), Ansell Limited, Medline Industries, Inc., Paul Hartmann AG, Fortive, Solventum, Metrex Research, LLC, Diversey Holdings, Ltd. and Sterigenics International LLC.

Key Developments:

In March 2026, Ecolab announced that it has entered into a definitive agreement to acquire CoolIT Systems, a high-growth, high-margin leader in liquid cooling technology for next-gen AI data centers. CoolIT is expected to generate approximately $550 million in sales over the next 12 months. With CoolIT's rapid sales growth, the acquisition is expected to significantly strengthen the company's Global High-Tech growth engine and accelerate Global Water's organic sales growth rate by 2% and Ecolab's total organic sales growth rate by 1%.

In May 2025, 3M has reached an agreement that resolves all legacy claims related to the Chambers Works site in Salem County, New Jersey, currently owned by The Chemours Company and, before that, by DuPont. In addition, the settlement extends to PFAS-related claims that the State of New Jersey and its departments have, or may in the future have, against 3M.

Product Types Covered:

• Disinfectants & Sanitizers
• Sterilization Equipment
• Protective Barriers
• Antimicrobial Coatings & Materials
• Infection Control Consumables

Distribution Channels Covered:

• Hospital Pharmacies
• Retail Pharmacies
• Online Platforms
• Direct Institutional Sales

Applications Covered:

• Hospitals & Clinics
• Pharmaceutical & Biotechnology Companies
• Laboratories & Research Facilities
• Food & Beverage Processing
• Household & Community Settings

End Users Covered:

• Healthcare Providers
• Industrial Users
• Academic & Research Institutions
• Consumers

Regions Covered:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Netherlands
  • Belgium
  • Sweden
  • Switzerland
  • Poland
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Malaysia
  • Singapore
  • Vietnam
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Colombia
  • Chile
  • Peru
  • Rest of South America
• Rest of the World (RoW)
  • Middle East
• Saudi Arabia
• United Arab Emirates
• Qatar
• Israel
• Rest of Middle East
  • Africa
• South Africa
• Egypt
• Morocco
• Rest of Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

• 1.1 Market Snapshot and Key Highlights
• 1.2 Growth Drivers, Challenges, and Opportunities
• 1.3 Competitive Landscape Overview
• 1.4 Strategic Insights and Recommendations

2 Research Framework

• 2.1 Study Objectives and Scope
• 2.2 Stakeholder Analysis
• 2.3 Research Assumptions and Limitations
• 2.4 Research Methodology
  • 2.4.1 Data Collection (Primary and Secondary)
  • 2.4.2 Data Modeling and Estimation Techniques
  • 2.4.3 Data Validation and Triangulation
  • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

• 3.1 Market Definition and Structure
• 3.2 Key Market Drivers
• 3.3 Market Restraints and Challenges
• 3.4 Growth Opportunities and Investment Hotspots
• 3.5 Industry Threats and Risk Assessment
• 3.6 Technology and Innovation Landscape
• 3.7 Emerging and High-Growth Markets
• 3.8 Regulatory and Policy Environment
• 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

• 4.1 Porter's Five Forces Analysis
  • 4.1.1 Supplier Bargaining Power
  • 4.1.2 Buyer Bargaining Power
  • 4.1.3 Threat of Substitutes
  • 4.1.4 Threat of New Entrants
  • 4.1.5 Competitive Rivalry
• 4.2 Market Share Analysis of Key Players
• 4.3 Product Benchmarking and Performance Comparison

5 Global Antimicrobial & Infection Control Products Market, By Product Type

• 5.1 Disinfectants & Sanitizers
• 5.2 Sterilization Equipment
• 5.3 Protective Barriers
• 5.4 Antimicrobial Coatings & Materials
• 5.5 Infection Control Consumables

6 Global Antimicrobial & Infection Control Products Market, By Distribution Channel

• 6.1 Hospital Pharmacies
• 6.2 Retail Pharmacies
• 6.3 Online Platforms
• 6.4 Direct Institutional Sales

7 Global Antimicrobial & Infection Control Products Market, By Application

• 7.1 Hospitals & Clinics
• 7.2 Pharmaceutical & Biotechnology Companies
• 7.3 Laboratories & Research Facilities
• 7.4 Food & Beverage Processing
• 7.5 Household & Community Settings

8 Global Antimicrobial & Infection Control Products Market, By End User

• 8.1 Healthcare Providers
• 8.2 Industrial Users
• 8.3 Academic & Research Institutions
• 8.4 Consumers

9 Global Antimicrobial & Infection Control Products Market, By Geography

• 9.1 North America
  • 9.1.1 United States
  • 9.1.2 Canada
  • 9.1.3 Mexico
• 9.2 Europe
  • 9.2.1 United Kingdom
  • 9.2.2 Germany
  • 9.2.3 France
  • 9.2.4 Italy
  • 9.2.5 Spain
  • 9.2.6 Netherlands
  • 9.2.7 Belgium
  • 9.2.8 Sweden
  • 9.2.9 Switzerland
  • 9.2.10 Poland
  • 9.2.11 Rest of Europe
• 9.3 Asia Pacific
  • 9.3.1 China
  • 9.3.2 Japan
  • 9.3.3 India
  • 9.3.4 South Korea
  • 9.3.5 Australia
  • 9.3.6 Indonesia
  • 9.3.7 Thailand
  • 9.3.8 Malaysia
  • 9.3.9 Singapore
  • 9.3.10 Vietnam
  • 9.3.11 Rest of Asia Pacific
• 9.4 South America
  • 9.4.1 Brazil
  • 9.4.2 Argentina
  • 9.4.3 Colombia
  • 9.4.4 Chile
  • 9.4.5 Peru
  • 9.4.6 Rest of South America
• 9.5 Rest of the World (RoW)
  • 9.5.1 Middle East
    • 9.5.1.1 Saudi Arabia
    • 9.5.1.2 United Arab Emirates
    • 9.5.1.3 Qatar
    • 9.5.1.4 Israel
    • 9.5.1.5 Rest of Middle East
  • 9.5.2 Africa
    • 9.5.2.1 South Africa
    • 9.5.2.2 Egypt
    • 9.5.2.3 Morocco
    • 9.5.2.4 Rest of Africa

10 Strategic Market Intelligence

• 10.1 Industry Value Network and Supply Chain Assessment
• 10.2 White-Space and Opportunity Mapping
• 10.3 Product Evolution and Market Life Cycle Analysis
• 10.4 Channel, Distributor, and Go-to-Market Assessment

11 Industry Developments and Strategic Initiatives

• 11.1 Mergers and Acquisitions
• 11.2 Partnerships, Alliances, and Joint Ventures
• 11.3 New Product Launches and Certifications
• 11.4 Capacity Expansion and Investments
• 11.5 Other Strategic Initiatives

12 Company Profiles

• 12.1 3M Company
• 12.2 Steris plc
• 12.3 Ecolab Inc.
• 12.4 Getinge AB
• 12.5 Belimed AG
• 12.6 Reckitt Benckiser Group plc
• 12.7 B. Braun Melsungen AG
• 12.8 Kimberly-Clark Corporation
• 12.9 Cardinal Health, Inc.
• 12.10 Becton, Dickinson and Company (BD)
• 12.11 Ansell Limited
• 12.12 Medline Industries, Inc.
• 12.13 Paul Hartmann AG
• 12.14 Fortive
• 12.15 Solventum
• 12.16 Metrex Research, LLC
• 12.17 Diversey Holdings, Ltd.
• 12.18 Sterigenics International LLC